Neurogenesis and gliogenesis modulation in cerebral ischemia by CDK5 RNAi-based therapy
ABSTRACT: Cerebral ischemia is the third cause of death risk in Colombia and the first cause of physical disability worldwide. Different studies on the silencing of the cyclin-dependent kinase 5 (CDK5) have shown that reducing its activity is beneficial in ischemic contexts. However, its effect on n...
- Autores:
-
Cardona Gómez, Gloria Patricia
Muñoz Manco, Juan Ignacio
Gutiérrez Vargas, Johanna Andrea
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2018
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/36534
- Acceso en línea:
- https://hdl.handle.net/10495/36534
- Palabra clave:
- Isquemia Encefálica
Brain Ischemia
Neurogénesis
Quinasa 5 Dependiente de la Ciclina
Cyclin-Dependent Kinase 5
Estenosis Carotídea
Carotid Stenosis
Momento de Replicación del ADN
Período de Replicação do DNA
Terapia Molecular Dirigida
Molecular Targeted Therapy
Ratas Wistar
Rats, Wistar
Interferencia de ARN
RNA Interference
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-nd/4.0/